Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false question first answered
creator	label
publisher	pref label
tabling member	label

Search

1001918

	human indexable
	published
	registered interest
	answer date	12/11/2018
	date	05/11/2018
	date tabled	05/11/2018
	ddp created	05/11/2018 22:16:21
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/11/2018 22:35:43 14/11/2018 11:53:01
	hansard heading	Rare Diseases: Drugs
	house id	1
	identifier	188233
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	14/11/2018 11:21:33
	question text	To ask the Secretary of State for Health and Social Care, whether officials in his Department have had discussions with the Scottish Government on the (a) Patient and Clinician Engagement system, (b) its effect on approval rates for new rare disease medicines in Scotland and (c) potential lessons from that system for NHS England.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 188233
	type	WrittenParliamentaryQuestion
	uin	188233
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 14/11/2018 11:21:33
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1020384

	human indexable
	published
	registered interest
	answer date	10/12/2018
	date	05/12/2018
	date tabled	05/12/2018
	ddp created	05/12/2018 21:53:30
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/12/2018 22:07:52 12/12/2018 15:35:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	199471
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	12/12/2018 15:03:23
	question text	To ask the Secretary of State for Health and Social Care, when NHS England plans to publish the commercial framework referred to in the policy paper of 5 December 2018 entitled Voluntary scheme for branded medicines pricing and access.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 199471
	type	WrittenParliamentaryQuestion
	uin	199471
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 12/12/2018 15:03:23
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1023166

	human indexable
	published
	registered interest
	answer date	13/12/2018
	date	11/12/2018
	date tabled	11/12/2018
	ddp created	11/12/2018 19:39:17
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/12/2018 19:45:19 19/12/2018 12:35:02
	hansard heading	Rare Diseases: Drugs
	house id	1
	identifier	201214
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	19/12/2018 12:03:22
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 November 2018 to Question 188234 on Rare Diseases: Drugs, whether NICE can make a conditional recommendation for treatment for rare diseases that do not qualify for conditional recommendation through the cancer drugs fund.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 201214
	type	WrittenParliamentaryQuestion
	uin	201214
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 19/12/2018 12:03:22
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1023167

	human indexable
	published
	registered interest
	answer date	13/12/2018
	date	11/12/2018
	date tabled	11/12/2018
	ddp created	11/12/2018 19:39:19
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/12/2018 19:45:22 19/12/2018 12:36:03
	hansard heading	Rare Diseases: Drugs
	house id	1
	identifier	201215
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	19/12/2018 12:04:06
	question text	To ask the Secretary of State for Health and Social Care, with reference to his policy paper of 5 December 2018 entitled Voluntary scheme for branded medicines pricing and access, whether NICE plans to review the suitability of its technology appraisal methods for rare disease treatments that do not qualify for the highly specialised technologies programme.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 201215
	type	WrittenParliamentaryQuestion
	uin	201215
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 19/12/2018 12:04:06
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1037134

	human indexable
	published
	registered interest
	answer date	09/01/2019
	date	07/01/2019
	date tabled	07/01/2019
	ddp created	07/01/2019 22:59:35
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/01/2019 23:10:33 15/01/2019 12:57:02
	hansard heading	Continuing Care
	house id	1
	identifier	206023
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/01/2019 12:26:00
	question text	To ask the Secretary of State for Health and Social Care, how many claims for continuing care payments remain outstanding since the deadline for applications was set.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 206023
	type	WrittenParliamentaryQuestion
	uin	206023
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 15/01/2019 12:26:00
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1037136

	human indexable
	published
	registered interest
	answer date	09/01/2019
	date	07/01/2019
	date tabled	07/01/2019
	ddp created	07/01/2019 22:59:39
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/01/2019 15:15:39 15/01/2019 12:57:03
	hansard heading	Continuing Care
	house id	1
	identifier	206024
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/01/2019 12:25:12
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of funding the outstanding retrospective claims under the continuing care programme; what interest rate is being applied to such claims; and what estimate he has made of the average cost to the public purse of those outstanding claims.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 206024
	type	WrittenParliamentaryQuestion
	uin	206024
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 15/01/2019 12:25:12
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1037137

	human indexable
	published
	registered interest
	answer date	09/01/2019
	date	07/01/2019
	date tabled	07/01/2019
	ddp created	07/01/2019 22:59:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/01/2019 23:10:41 16/01/2019 17:52:01
	hansard heading	Orphan Drugs: Regulation
	house id	1
	identifier	206025
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	16/01/2019 17:20:56
	question text	To ask the Secretary of State for Health and Social Care, when his Department plans to publish its consultation on the regulation of orphan drugs after the UK leaves the EU.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 206025
	type	WrittenParliamentaryQuestion
	uin	206025
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 16/01/2019 17:20:56
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1037139

	human indexable
	published
	registered interest
	answer date	09/01/2019
	date	07/01/2019
	date tabled	07/01/2019
	ddp created	07/01/2019 22:59:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/01/2019 23:10:45 15/01/2019 16:45:09
	hansard heading	Rare Diseases
	house id	1
	identifier	206027
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/01/2019 16:13:10
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the availability of treatments for patients with rare diseases since the introduction of the Orphan Medical Product Regulation 2000.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 206027
	type	WrittenParliamentaryQuestion
	uin	206027
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 15/01/2019 16:13:10
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1110545

	human indexable
	published
	registered interest
	answer date	11/04/2019
	date	09/04/2019
	date tabled	09/04/2019
	ddp created	09/04/2019 18:45:12
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/04/2019 19:15:47 16/04/2019 15:11:16
	hansard heading	Irlen Syndrome: Medical Treatments
	house id	1
	identifier	242928
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	16/04/2019 14:30:02
	question text	To ask the Secretary of State for Health and Social Care, what (a) treatments and (b) support is provided by the NHS to (i) adults and (ii) children with Meares-Irlen Syndrome.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 242928
	type	WrittenParliamentaryQuestion
	uin	242928
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 16/04/2019 14:30:02
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith

1131201

	human indexable
	published
	registered interest
	answer date	13/06/2019
	date	11/06/2019
	date tabled	11/06/2019
	ddp created	11/06/2019 17:54:56
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/06/2019 18:05:15 19/06/2019 16:47:01
	hansard heading	Care Homes: Abuse
	house id	1
	identifier	263230
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	19/06/2019 16:15:21
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) residents of care homes and (b) the families of those residents in England are aware of mechanisms for reporting abuse.
	session	2017/19
	session number	1
	tabling member constituency	Bury North
	tabling member printed	James Frith
	title	House of Commons Tabled Parliamentary Question 2017/19 263230
	type	WrittenParliamentaryQuestion
	uin	263230
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 19/06/2019 16:15:21
	creator	4637 label Biography information for James Frith
	publisher	25259 pref label House of Commons
	tabling member	4637 label Biography information for James Frith